SK172897A3 - Composition based on probiotics, method for the preparation of probiotic bacteria being contained in the composition, and usage of said composition - Google Patents
Composition based on probiotics, method for the preparation of probiotic bacteria being contained in the composition, and usage of said composition Download PDFInfo
- Publication number
- SK172897A3 SK172897A3 SK1728-97A SK172897A SK172897A3 SK 172897 A3 SK172897 A3 SK 172897A3 SK 172897 A SK172897 A SK 172897A SK 172897 A3 SK172897 A3 SK 172897A3
- Authority
- SK
- Slovakia
- Prior art keywords
- composition
- bacteria
- probiotic
- selenium
- lactic acid
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Prostriedok na báze probiotík, spôsob prípravy probiotických baktérií obsiahnutých v prostriedku a použitie tohto prostriedku.A composition based on probiotics, a process for preparing the probiotic bacteria contained in the composition and the use of the composition.
Oblasť technikyTechnical field
Vynález sa týka prostriedku na báze probiotík, spôsobu prípravy probiotických baktérií obsiahnutých v prostriedku a použitie tohto prostriedku.The present invention relates to a composition based on probiotics, to a process for preparing the probiotic bacteria contained in the composition and to the use of the composition.
Doterajší stav technikyBACKGROUND OF THE INVENTION
Probiotiká sú živé organizmy vyskytujúce sa najmä v niektorých potravinách, napríklad v mliečnych produktoch pripravených fermentáciou, ktoré priaznivo pôsobia na živočíšny a ľudský organizmus tým, že zabezpečujú optimálne zloženie črevnej mikroflóry. Existuje už veľa dôkazov, že baktérie mliečneho kysnutia sa vyznačujú antimutagénnymi, antikarcinogénnymi,imunostimulačnými a anticholesterolemickými vlastnosťami, v dôsledku čoho sa im pripisuje významný podiel aj na prevencii infekčných, nádorových a srdcovocievnych ochorení, ako aj pri odd’alovani nástupu senescencie ( Ebringer. L., et al.: Anti-mutagenic and imuno-stimulatory properties of lactic acid bacteria. World J. Microbiol. Biotechnol. 11, 294-298, 1995; Bakalinsky, A.T., et al.: Antimutagenicity of yoghurt. Mut. Res. 350, 199-200, 1996; Pool- Zobel, B.L., et al.: Antigenotoxic properties of lactic acid bacteria in the Salmonella typhimurium mutagenicity assay. Nutr. Cancer 20, 261-270, 1993; Singh, J., et al.: Bifidobacterium longum, a lactic acid producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 18, /4/, 833-841, 1997; Zacconi, c., et al.: Sérum cholesterol levels in axenic mice colonized with Enterococcus faecium and Lactobacillus acidophilus. Microbiologica 15: 413-418, 1992; Challa, A., et al.: Bifidobacterium longum and lactulose supress azoxymethane-induced colonic aberant crypt foci in rats. Carcinogenesis 18: 517-521,1997; Orhage, K., et al.: Binding of mutagenic heterocyclic amines by intestinal and lactic bacteria. J. Dairy Sci. 78: 491-497, 1995; Hadault, S., et al.. Antagonistic activity exerted in vitro and in 'i vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl. Environ. Microbiol. 62: 513-518, 1997).Probiotics are living organisms mainly found in certain foods, for example in dairy products prepared by fermentation, which have a beneficial effect on the animal and human organism by ensuring optimal composition of the intestinal microflora. There is ample evidence that lactic acid bacteria are characterized by antimutagenic, anticarcinogenic, immunostimulatory and anticholesterolemic properties, as a result of which they have been implicated in the prevention of infectious, tumor and cardiovascular diseases as well as in delaying the onset of senescence (Ebr. , et al .: Anti-mutagenic and immuno-stimulatory properties of lactic acid bacteria World J. Microbiol Biotechnol., 11, 294-298, 1995; Bakalinsky, AT, et al. 350, 199-200, 1996, Pool-Zobel, BL, et al .: Antigenotoxic Properties of Lactic Acid Bacteria in the Salmonella Typhimurium Mutagenicity Assay Nutr.Cancer 20, 261-270, 1993, Singh, J., et al. : Bifidobacterium longum, a lactic acid producing intestinal bacterium inhibiting colon cancer and modulates the intermediate biomarkers of colon carcinogenesis, Carcinogenesis 18, 4, 833-841, 1997; Zacconi, c., Et al .: Serum cholesterol level with inocular mice colonized with Enterococcus faecium and Lactobacillus acidophilus. Microbiologica 15: 413-418 (1992); Challa, A., et al .: Bifidobacterium longum and lactulose supress azoxymethane-induced colonic aberant crypt foci in rats. Carcinogenesis 18: 517-521, 1997; Orhage, K., et al .: Binding of mutagenic heterocyclic amines by intestinal and lactic bacteria. J. Dairy Sci. 78: 491-497 (1995); Hadault, S., et al. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl. Environ. Microbiol. 62: 513-518 (1997).
Selén patrí do skupiny esenciálnych stopových prvkov potrebných pre udržanie optimálnej aktivity glutatiónperoxidázy. Tento enzým hrá významnú úlohu pri ochrane biologických membrán proti škodlivým účinkom reaktívnych foriem kyslíka. Nedostatok tohto mikroelementu v potrave je jedným z dôležitých rizikových faktorov zvýšeného výskytu rakoviny ( Combs, G.F., and Combs, S.B.,: The role of selenium in nutrition, Academic Press, Orlando, 1986; Tex, G., et al., : Low plasma selenium as a risk factor for cancer death in middleaged men. Nutr. Cancer 10: 221-229, 1987; Lee, B.J., et al.,: Molecular biology of selenium and its role in human health. Molecules and Cells 6: 509-520, 1996; Fleet, J.C. and Mayer, J.,: Dietary selenium repletion may reduce cancer incidence in people at high risk who live in areas with low soil selenium. Nutr. Rev. 55: 277-279,1997).Selenium belongs to the group of essential trace elements required to maintain optimal glutathione peroxidase activity. This enzyme plays an important role in protecting biological membranes against the damaging effects of reactive oxygen species. The lack of this microelement in food is one of the important risk factors for increased cancer incidence (Combs, GF, and Combs, SB: The role of selenium in nutrition, Academic Press, Orlando, 1986; Tex, G., et al.,: Low Plasma Selenium as a Risk Factor for Cancer Death in Middleaged Men, Nutr.Cancer 10: 221-229, 1987; Lee, BJ, et al., Molecular Biology of Selenium and Its Role in Human Health Molecules and Cells 6: 509 -520, 1996; Fleet, JC and Mayer, J.,: Dietary selenium repletion may reduce cancer incidence in people at high risk who live in areas with low soil selenium (Nutr. Rev. 55: 277-279, 1997).
Vo všeobecnosti je príjem selénu potravou pomerne nízky. Je pravdepodobné, že časť populácie nedostáva v potrave ani dolnú odporúčanú dávku ( 50 pg/deň). Nedostatok selénu v potrave sa rieši prihnojovaním anorganickými sólami selénu, čim sa dostáva tento prvok do potravinového reťazca. Ďalší spôsob spočíva v príprave tabliet obsahujúcich anorganické soli selénu, avšak, selén v anorganickej forme sa na rozdiel od selénu viazaného v bielkovinách ťažšie utilizuje.In general, food intake of selenium is relatively low. It is likely that part of the population does not receive even the lower recommended dose (50 pg / day) in the diet. Selenium deficiency in the diet is addressed by fertilization with inorganic selenium soles, which enters this element into the food chain. Another method consists in preparing tablets containing inorganic salts of selenium, but selenium in inorganic form is more difficult to utilize than protein-bound selenium.
Podstata vynálezuSUMMARY OF THE INVENTION
Uvedené nevýhody do značnej miery odstraňuje prostriedok na báze probiotík, ktorého podstata spočíva v tom, že je tvorený lyofilizovanými probiotickými baktériami mliečneho kysnutia s organicky naviazaným selénom v množstve 410 až 420 pg Se/lg lyofilizovaných baktérií, pričom obsah živých zárodkov v 1 g lyofilizovaných baktérií je 2,3 až 9,0 . 10 11 The above-mentioned disadvantages are largely eliminated by the probiotics-based composition consisting of lyophilized probiotic lactic acid bacteria with organically bound selenium in an amount of 410 to 420 pg Se / lg of lyophilized bacteria, with live germ content in 1 g of lyophilized bacteria is 2.3 to 9.0. 10 11
Probiotickými baktériami mliečneho kysnutia sú výhodne baktérie rodov Enterococcus,The probiotic lactic acid bacteria are preferably Enterococcus spp.
Lactobacillus alebo Bifidobacterium.Lactobacillus or Bifidobacterium.
Podstata spôsobu prípravy probiotických baktérií obsiahnutých v tomto prostriedku spočíva v tom, že baktérie mliečneho kysnutia sa kultivujú v kultivačnom médiu za prídavku anorganickej soli selénu v množstve 0,00033 až 0,00046 % hmotn. pri teplote 37° až 42° CThe essence of the process for preparing the probiotic bacteria contained in the composition is that the lactic acid bacteria are cultured in a culture medium with the addition of an inorganic salt of selenium in an amount of 0.00033 to 0.00046% by weight. at 37 ° to 42 ° C
-3počas 15 až 18 hodín, vzniknutý produkt sa oddelí, premyje sterilným fyziologickým roztokom a nakoniec sa podrobí lyofílizácii.After 15 to 18 hours, the resulting product was collected, washed with sterile saline and finally subjected to lyophilization.
U niektorých druhov baktérií, konkrétne u baktérí rodu Bifidobacterium, kultivácia prebieha za anaerobných podmienok pod atmosférou CO2.In some species of bacteria, particularly Bifidobacterium, cultivation takes place under anaerobic conditions under a CO 2 atmosphere.
Podstatou vynálezu je aj použitie predmetného prostriedku na prípravu potravinárskych výrobkov s probiotickými účinkami.The present invention also provides the use of the present composition for the preparation of food products having probiotic effects.
Prostriedok podľa vynálezu má vlastnosti probiotík a má schopnosť zásobovať organizmus esenciálnym selénom viazaným do organickej formy. Zabudovanie selénu do bielkovín probiotických baktérií možno považovať za významný prostriedok slúžiaci pre znižovanie rizika civilizačných ochorení. Baktérie mliečneho kysnutia okrem pôvodných priaznivých účinkov na zdravie človeka sa tak stávajú aj nosičmi organických foriem selénu, ktoré majú výhodnejšie vlastnosti oproti anorganickým selénovým soliam. Selenoaminokyseliny, ktoré sa nachádzajú v bielkovinách mliečnych baktérií sa stávajú v gastrointestinálnom trakte človeka prekurzormi pre biosyntézu glutationperoxidázy a ďalších ochranných enzýmov s antioxidačnými účinkami.The composition of the invention has the properties of probiotics and has the ability to supply the organism with essential selenium bound to an organic form. The incorporation of selenium into the proteins of probiotic bacteria can be considered as an important means of reducing the risk of civilization diseases. Thus, in addition to the original beneficial effects on human health, lactic acid bacteria also become carriers of organic forms of selenium, which have more advantageous properties over inorganic selenium salts. The selenoamino acids found in lactic acid proteins become precursors to the biosynthesis of glutathione peroxidase and other protective enzymes with antioxidant effects in the human gastrointestinal tract.
Príklady uskutočnenia vynálezuDETAILED DESCRIPTION OF THE INVENTION
Príklad 1Example 1
Príprava probiotika s obsahom organicky viazaného selénu kultiváciou Enterococcus faecium Baktérie rodu Enterococcus faecium sa stacionárne kultivovali v objeme 10 1 v sklenenej nádobe uzavretej zátkou z papierovej vaty na pôde, ktorá mala nasledovné zloženie: peptón 10,0 g, mäsový extrakt 10,0 g, kvasničný extrakt 5,0 g, glukóza 20,0 g, tween 80 1,0 g, citrát amónny 2,0 g, octan sodný 5,0 g, síran horečnatý 0,1 g, síran manganatý 0,05 g, hydrofosforečnan draselný 2,0 g, destilovaná voda 1000 ml. pH pôdy sa upravilo na hodnotuPreparation of probiotic containing organically bound selenium by cultivation of Enterococcus faecium Bacteria of the genus Enterococcus faecium were stationary cultivated in a volume of 10 L in a glass container closed with a cotton wool plug on the soil having the following composition: peptone 10.0 g, meat extract 10.0 g, yeast extract 5.0 g, glucose 20.0 g, tween 80 1.0 g, ammonium citrate 2.0 g, sodium acetate 5.0 g, magnesium sulfate 0.1 g, manganese sulfate 0.05 g, potassium hydrogen phosphate 2.0 g, distilled water 1000 ml. The pH of the soil was adjusted to pH
6,5 ± 0,2 pred sterilizáciou. Osobitne sa pripravil sterilný roztok Na2 SeO·? . 5 H2 O v koncentrácii 0,33 % hmotn. v destilovanej vode. Sterilná kultivačná pôda sa naočkovala s 11 až 12 hodinovou kultúrou Enterococcus faecium a pridal sa sterilný roztok Na2 SeCb .5 H2 O v množstve 10 ml . Doba kultivácie pri 37° C bola 15 hodín.. Po skončení fermentácie sa6.5 ± 0.2 prior to sterilization. In particular, a sterile Na 2 SeO · solution was prepared. . 5 H 2 O at a concentration of 0.33 wt. in distilled water. The sterile culture broth was inoculated with an 11-12 hour culture of Enterococcus faecium and a sterile solution of Na 2 SeCl 5 · 5 H 2 O in an amount of 10 ml was added. The cultivation time at 37 ° C was 15 hours
-4bunky separovali centnfugovaním pri 3000 ot./min., trikrát premyli sterilným fyziologickým roztokom a nakoniac sa lyofilizovalí.The -4 cells were separated by centrifugation at 3000 rpm, washed three times with sterile saline, and finally lyophilized.
Lyofilizované bunky mikroorganizmu sa uchovávajú v uzavretej nádobe pri 4° C, pričom ich životaschopnosť sa nemení v priebehu 6 mesiacov a má hodnotu 2,3 . 10*1 živých baktérii/ 1 g sušiny. Obsah organicky viazaného selénu v baktériách sa stanovil atómovou absorpčnou spektrometriou a mal hodnotu 410 pg Se/ lg lyofílizovaných baktérií.The lyophilized cells of the microorganism are stored in a sealed container at 4 ° C, and their viability does not change within 6 months and is 2.3. 10 * 1 live bacteria / 1 g dry matter. The content of organically bound selenium in the bacteria was determined by atomic absorption spectrometry and had a value of 410 pg Se / 1g of lyophilized bacteria.
Príklad 2Example 2
Príprava probiotika s obsahom organicky viazaného selénu kultiváciou Lactobacillus acidophilus.Preparation of probiotic containing organically bound selenium by cultivation of Lactobacillus acidophilus.
Baktérie druhu Lactobacillus acidophilus sa kultivovali podľa postupu uvedeného v príklade 1 s tým rozdielom, že sa pridalo 12 ml sterilného roztoku Na2 SeO3 . 5 H2 O a kultivácia prebiehala 17 hodín pri teplote 40° C.Lactobacillus acidophilus was cultured according to the procedure of Example 1 except that 12 ml of sterile Na 2 SeO 3 solution was added. 5 H 2 O and cultivated at 40 ° C for 17 hours.
Obsah živých zárodkov v lg lyofílizovaných baktérií bol 6,0 . 101’ a obsah organicky viazaného selénu bol 415 pg Se/ lg lyofílizovaných baktérií.The live germ content in 1g of lyophilized bacteria was 6.0. 10 1 'and the organically bound selenium content was 415 µg Se / 1g of lyophilized bacteria.
Príklad 3Example 3
Príprava probiotika s obsahom organicky viazaného selénu kultiváciou Bifidobacterium longum.Preparation of probiotic containing organically bound selenium by cultivation of Bifidobacterium longum.
Baktérie druhu Bifidobacterium longum.sa kultivovali podľa postupu uvedeného v príklade 1 s tým rozdielom, že sa pridalo 14 ml sterilného roztoku Na2 SeO? . 5 H2 O a kultivácia prebiehala za anaeróbnych podmienok pod atmosférou CO2 18 hodín pri teplote 40°C.The bacteria of the species Bifidobacterium longum were cultured according to the procedure described in Example 1 except that 14 ml of sterile Na 2 SeO 2 solution was added. . 5 H 2 O and cultivation under anaerobic conditions under CO 2 atmosphere for 18 hours at 40 ° C.
Obsah živých zárodkov v lg lyofílizovaných baktérií bol 9,0 . 1011 a obsah organicky viazaného selénu bol 420 pg Se/ lg lyofílizovaných baktérií.The live germ content in 1g of lyophilized bacteria was 9.0. 10 11 and the organically bound selenium was 420 Pg / g lyophilised bacteria.
Priemyselná využiteľnosťIndustrial usability
Prostriedok podľa vynálezu má využitie vo farmaceutickom priemysle na výrobu preparátov s preventívnym alebo terapeutickým uplatnením v humánnej a veterinárnej medicíne, taktiež aj v potravinárskom priemysle ako prídavok k rôznym druhom potravín, ako sú jogurty, acidofilné mlieko, jedlé tuky, cukrárenské výrobky.The composition according to the invention has utility in the pharmaceutical industry for the production of preparations with preventive or therapeutic application in human and veterinary medicine, as well as in the food industry as an additive to various kinds of foods such as yoghurts, acidophilic milk, edible fats, confectionery products.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SK1728-97A SK280832B6 (en) | 1997-12-18 | 1997-12-18 | Composition based on probiotics, method for the preparation of probiotic bacteria being contained in the composition, and usage of said composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SK1728-97A SK280832B6 (en) | 1997-12-18 | 1997-12-18 | Composition based on probiotics, method for the preparation of probiotic bacteria being contained in the composition, and usage of said composition |
Publications (2)
Publication Number | Publication Date |
---|---|
SK172897A3 true SK172897A3 (en) | 1999-07-12 |
SK280832B6 SK280832B6 (en) | 2000-08-14 |
Family
ID=20434781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1728-97A SK280832B6 (en) | 1997-12-18 | 1997-12-18 | Composition based on probiotics, method for the preparation of probiotic bacteria being contained in the composition, and usage of said composition |
Country Status (1)
Country | Link |
---|---|
SK (1) | SK280832B6 (en) |
-
1997
- 1997-12-18 SK SK1728-97A patent/SK280832B6/en unknown
Also Published As
Publication number | Publication date |
---|---|
SK280832B6 (en) | 2000-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Beheshtipour et al. | Supplementation of Spirulina platensis and Chlorella vulgaris algae into probiotic fermented milks | |
EP2308566B1 (en) | Use of orally administered probiotic bifidobacteria for human beauty benefits | |
KR100632718B1 (en) | Improved microbial preparations | |
KR100514592B1 (en) | New strains capable of producing conjugated linoleic acid, capsulated composition comprising them, and the functional food using them | |
CN100455203C (en) | A probiotic composition comprising at least two lactic acid bacterial strains which are able to colonise the gastrointestinal tracts in combination with having intestinal survival property, intestinal | |
US7250162B2 (en) | Lactic acid bacteria inhibiting halitosis | |
ES2356119T3 (en) | LACTOBACILLUS FERMENTUM ME-3 MICROORGANISM strain as a new anti-oxidant probiotic. | |
CN103189499A (en) | Agent for improvement in survival of lactic acid bacterium and/or bifidobacterium | |
KR102251295B1 (en) | A composition for preventing or relieving hangover of the comprising heat-killed lactobacillus salivarius v133 as an active ingredient | |
JP5505298B2 (en) | Helicobacter pylori growth inhibitor and method for producing the same | |
JP4183371B2 (en) | Manufacturing method of fermented turmeric | |
JP3520012B2 (en) | Composition suitable as a nutrient supplement and for treating intestinal disorders and modifying the bacterial flora | |
Sip et al. | Probiotics and prebiotics | |
KR102005617B1 (en) | Lactobacillus plantarum F.M.B #31 as a novel strain with anti-cholesterol activity and use thereof | |
Chaia et al. | Dairy propionibacteria from milk or cheese diets remain viable and enhance propionic acid production in the mouse cecum | |
KR101454228B1 (en) | Lipid-metabolism-ameliorating agent | |
KR100868777B1 (en) | Food composition with Bifidobacterium adolescentis to utilize RS-3 type resistant starch | |
JP2002306125A (en) | Probiotic-containing nutrient composition for infant in packed container | |
KR20190072923A (en) | Antioxidant and Immune-enhancing functional beverage and food composition comprising the extract of edible flowers fermented by lactic acid bacteria and preparation method of the same | |
KR100720025B1 (en) | Probiotic lactic acid bacteria and composition comprising the same | |
SK172897A3 (en) | Composition based on probiotics, method for the preparation of probiotic bacteria being contained in the composition, and usage of said composition | |
RU2225215C2 (en) | Application of propionic acid microorganisms for formation of propionic acid and/or propionates in colon intestine | |
Alslibi et al. | Effect of Dunaliella salina on enhancing viability of probiotic and the nutritional value | |
Parada et al. | Lactic acid fermented products as vehicles for probiotics | |
JPH03191779A (en) | Propagation accelerator for lactobacillus bifidus |